Cambridge Investment Research Advisors’s Vanguard US Value Factor ETF VFVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.46M Sell
9,827
-481
-5% -$69K ﹤0.01% 1950
2026
Q1
$1.39M Sell
10,308
-38
-0.4% -$5.25K ﹤0.01% 1894
2025
Q4
$1.37M Buy
10,346
+1,199
+13% +$155K ﹤0.01% 1851
2025
Q3
$1.17M Buy
9,147
+1,011
+12% +$126K ﹤0.01% 1931
2025
Q2
$963K Buy
8,136
+581
+8% +$64.8K ﹤0.01% 1985
2025
Q1
$861K Buy
7,555
+93
+1% +$11.1K ﹤0.01% 1983
2024
Q4
$883K Buy
7,462
+738
+11% +$90.7K ﹤0.01% 1972
2024
Q3
$810K Sell
6,724
-178
-3% -$20.9K ﹤0.01% 2023
2024
Q2
$780K Buy
6,902
+2,733
+66% +$313K ﹤0.01% 1948
2024
Q1
$497K Buy
4,169
+417
+11% +$46.9K ﹤0.01% 2280
2023
Q4
$423K Buy
3,752
+6
+0.2% +$613 ﹤0.01% 2331
2023
Q3
$375K Buy
3,746
+55
+1% +$5.67K ﹤0.01% 2324
2023
Q2
$368K Buy
+3,691
New +$354K ﹤0.01% 2370

Other funds holding VFVA

Cambridge Investment Research Advisors's VFVA Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Vanguard US Value Factor ETF (VFVA) stake by 4.7% in Q2 2026, selling an estimated $69K and leaving 9,827 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #1950.

Cambridge Investment Research Advisors first reported a position in VFVA in Q2 2023 and has held it in 13 quarters since. 93 funds tracked by Wall St. Rank hold VFVA as of Q2 2026.

  • Cambridge Investment Research Advisors held 9,827 shares of Vanguard US Value Factor ETF worth $1.46M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 481 Vanguard US Value Factor ETF shares in Q2 2026, an estimated $69K.
  • Vanguard US Value Factor ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1950 holding.
  • Cambridge Investment Research Advisors first reported a position in Vanguard US Value Factor ETF in Q2 2023 and has held it in 13 quarters since.
  • 93 funds tracked by Wall St. Rank held Vanguard US Value Factor ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.